4/A//SEC Filing
LaFrence Andrew D.C. 4/A
Accession 0001493152-21-032696
CIK 0001349929other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:30 PM ET
Size
6.4 KB
Accession
0001493152-21-032696
Insider Transaction Report
Form 4/AAmended
Vyant Bio, Inc.VYNT
LaFrence Andrew D.C.
Chief Financial Officer
Transactions
- Purchase
Common Stock, $0.0001 par value
2021-11-23$2.00/sh+5,000$9,998→ 34,292 total
Holdings
- 29,825(indirect: By Trust)
Common Stock, $0.0001 par value
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.9995 to $2.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- [F2]Includes 3,000 shares previously held directly by the Reporting Person which were transferred to this joint trust account.
Documents
Issuer
Vyant Bio, Inc.
CIK 0001349929
Entity typeother
Related Parties
1- filerCIK 0001850633
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 4:30 PM ET
- Size
- 6.4 KB